{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:45:43Z","timestamp":1792111543593,"version":"4.4.0"},"reference-count":46,"publisher":"The Endocrine Society","issue":"11","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Congenital lipodystrophies (LDs), including congenital generalized LD (CGL) and familial partial LD (FPLD), are rare disorders characterized by absent or abnormal adipose tissue distribution, leading to clinical, hormonal, and metabolic complications. Although these systemic features are well described, data on bone involvement are limited. This literature review summarizes current evidence on bone manifestations in genetic LDs and potential underlying mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search was performed in PubMed, EMBASE, and the Cochrane Library using terms related to LD and bone outcomes. No restrictions on date, language, or study design were applied. Studies reporting bone-related outcomes in genetic LD in humans were included. Study quality was assessed using PRISMA guidelines and the JBI checklist.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 2632 studies identified, 15 met the inclusion criteria. Most focused on CGL1 and CGL2; no studies were found on CGL3 or CGL4. Reported bone abnormalities in CGL1 and CGL2 included osteolytic lesions, bone cysts, osteosclerosis, and pseudo-osteopoikilosis, predominantly in long bones. Bone mineral density (BMD) was generally normal to high at trabecular sites. In contrast, FPLD2 was characterized by reduced BMD at cortical sites and lower trabecular bone score, suggesting impaired bone quality. Proposed mechanisms include reduced bone marrow adipose tissue, disrupted marrow fat conversion, and altered endocrine signaling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Bone abnormalities are characteristic yet often underrecognized features of genetic LDs, particularly CGL1 and CGL2. Current evidence underlines the broad skeletal impact of adipose dysfunction and highlights the need for standardized, genetically stratified studies to clarify bone risk and guide clinical management in congenital LD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgag256","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T06:14:09Z","timestamp":1783318449000},"page":"3005-3011","source":"Crossref","is-referenced-by-count":1,"title":["Bone phenotype of patients with genetic forms of lipodystrophy: a systematic review of literature"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2216-235X","authenticated-orcid":false,"given":"Elif","family":"Kusgozoglu","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]},{"name":"Department of Internal Medicine, Division of Endocrinology, Center for Rare Endocrine and Bone Conditions, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4461-4293","authenticated-orcid":false,"given":"Daniela Q C M","family":"Barge-Schaapveld","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8455-4988","authenticated-orcid":false,"given":"Patrick C N","family":"Rensen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]},{"name":"Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1052-1119","authenticated-orcid":false,"given":"Tim","family":"Roek","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]},{"name":"Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9167-4056","authenticated-orcid":false,"given":"Hester","family":"Vlaardingerbroek","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]},{"name":"Department of Pediatrics, Division of Pediatric Endocrinology, Willem Alexander Children's Hospital, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4264-7972","authenticated-orcid":false,"given":"Ingrid M","family":"Jazet","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]},{"name":"Department of Internal Medicine, Division of Endocrinology, Center for Rare Endocrine and Bone Conditions, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5035-127X","authenticated-orcid":false,"given":"Natasha M","family":"Appelman-Dijkstra","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]},{"name":"Department of Internal Medicine, Division of Endocrinology, Center for Rare Endocrine and Bone Conditions, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"issue":"2","key":"2026101520031714800_dgag256-B1","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4158\/EP09154.RA","article-title":"Clinical classification and treatment of congenital and acquired lipodystrophy","volume":"16","author":"Chan","year":"2010","journal-title":"Endocr Pract"},{"issue":"11","key":"2026101520031714800_dgag256-B2","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.2011-1159","article-title":"Lipodystrophies: genetic and acquired body fat disorders","volume":"96","author":"Garg","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026101520031714800_dgag256-B3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/jhg.2013.107","article-title":"Exploring the pathophysiology behind the more common genetic and acquired lipodystrophies","volume":"59","author":"Nolis","year":"2014","journal-title":"J Hum Genet"},{"issue":"3","key":"2026101520031714800_dgag256-B4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrendo.2010.199","article-title":"Lipodystrophy: pathophysiology and advances in treatment","volume":"7","author":"Fiorenza","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"2026101520031714800_dgag256-B5","first-page":"104070","article-title":"Generalized lipoatrophy syndromes","volume":"50","author":"Vigouroux","year":"2021","journal-title":"Presse Med"},{"issue":"12","key":"2026101520031714800_dgag256-B6","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1210\/jc.2016-2466","article-title":"The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline","volume":"101","author":"Brown","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026101520031714800_dgag256-B7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ando.2024.05.015","article-title":"Partial lipodystrophy: clinical presentation and treatment","volume":"85","author":"Mosbah","year":"2024","journal-title":"Ann Endocrinol (Paris)"},{"key":"2026101520031714800_dgag256-B8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2147\/DMSO.S130810","article-title":"Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges","volume":"10","author":"Chiquette","year":"2017","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"9","key":"2026101520031714800_dgag256-B9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrendo.2015.123","article-title":"Congenital generalized lipodystrophies: new insights into metabolic dysfunction","volume":"11","author":"Patni","year":"2015","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2026101520031714800_dgag256-B10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jocd.2016.10.002","article-title":"Bone density in patients with Berardinelli-Seip congenital lipodystrophy is higher in trabecular sites and in type 2 patients","volume":"21","author":"Lima","year":"2018","journal-title":"J Clin Densitom"},{"issue":"Suppl 1","key":"2026101520031714800_dgag256-B11","doi-asserted-by":"crossref","first-page":"A271","DOI":"10.1210\/jendso\/bvab048.550","article-title":"Body composition and bone mineral differences according to lamin A (LMNA) genotype in familial partial lipodystrophy type 2","volume":"5","author":"de Freitas","year":"2021","journal-title":"J Endocr Soc"},{"issue":"6","key":"2026101520031714800_dgag256-B12","doi-asserted-by":"crossref","first-page":"e1008244","DOI":"10.1371\/journal.pgen.1008244","article-title":"Congenital lipodystrophy induces severe osteosclerosis","volume":"15","author":"Zou","year":"2019","journal-title":"PLoS Genet"},{"key":"2026101520031714800_dgag256-B13","doi-asserted-by":"crossref","unstructured":"Kusgozoglu E, Barge-Schaapveld DQCM, Rensen PCN, et al \u00a0Supplementary materials for \u201cBone phenotype of patients with genetic forms of lipodystrophy: a systematic review of literature\u201d. Zenodo. Published June 4, 2026. 10.5281\/zenodo.20546341","DOI":"10.1210\/clinem\/dgag256"},{"issue":"6","key":"2026101520031714800_dgag256-B14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF00241817","article-title":"The skeleton in congenital generalized lipodystrophy: evaluation using whole-body radiographic surveys, magnetic resonance imaging and technetium-99m bone scintigraphy","volume":"21","author":"Fleckenstein","year":"1992","journal-title":"Skeletal Radiol"},{"issue":"7715","key":"2026101520031714800_dgag256-B15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0140-6736(71)92085-X","article-title":"Bone lesions in congenital generalised lipodystrophy","volume":"298","author":"G\u00fcell-Gonz\u00e1lez","year":"1971","journal-title":"Lancet"},{"key":"2026101520031714800_dgag256-B16","doi-asserted-by":"crossref","first-page":"1326700","DOI":"10.3389\/fendo.2024.1326700","article-title":"Heterogeneity and high prevalence of bone manifestations, and bone mineral density in congenital generalized lipodystrophy subtypes 1 and 2","volume":"15","author":"Freire","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"s413","key":"2026101520031714800_dgag256-B17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1651-2227.1996.tb14265.x","article-title":"Radiological features in generalized lipodystrophy","volume":"85","author":"Westvik","year":"1996","journal-title":"Acta Paediatr"},{"issue":"7","key":"2026101520031714800_dgag256-B18","doi-asserted-by":"crossref","first-page":"764","DOI":"10.4158\/EP.13.7.764","article-title":"High bone mass associated with Berardinelli lipodystrophy","volume":"13","author":"Bandeira","year":"2007","journal-title":"Endocr Pract"},{"issue":"11","key":"2026101520031714800_dgag256-B19","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00256-016-2457-9","article-title":"Bone imaging findings in genetic and acquired lipodystrophic syndromes: an imaging study of 24 cases","volume":"45","author":"Teboul-Cor\u00e9","year":"2016","journal-title":"Skeletal Radiol"},{"issue":"9","key":"2026101520031714800_dgag256-B20","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s11604-007-0166-y","article-title":"Computed tomography findings of congenital generalized lipodystrophy: multiple nodular fatty liver and diffuse sclerosis of bones","volume":"25","author":"Shinya","year":"2007","journal-title":"Radiat Med"},{"issue":"1","key":"2026101520031714800_dgag256-B21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cen.13504","article-title":"Bone mineral density in familial partial lipodystrophy","volume":"88","author":"Fern\u00e1ndez-Pombo","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"17","key":"2026101520031714800_dgag256-B22","doi-asserted-by":"crossref","first-page":"13118","DOI":"10.3390\/ijms241713118","article-title":"Refining evaluation of bone mass and adipose distribution in Dunnigan syndrome","volume":"24","author":"Moreira","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026101520031714800_dgag256-B23","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3389\/fendo.2018.00694","article-title":"Bone marrow fat and hematopoiesis","volume":"9","author":"Wang","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"2026101520031714800_dgag256-B24","doi-asserted-by":"crossref","first-page":"E1493","DOI":"10.1210\/jc.2014-1353","article-title":"Bone mineral content in patients with congenital generalized lipodystrophy is unaffected by metreleptin replacement therapy","volume":"99","author":"Christensen","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"2026101520031714800_dgag256-B25","doi-asserted-by":"crossref","first-page":"9724","DOI":"10.3390\/ijerph18189724","article-title":"Bone mineral density in congenital generalized lipodystrophy: the role of bone marrow tissue, adipokines, and insulin resistance","volume":"18","author":"Freire","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"2026101520031714800_dgag256-B26","first-page":"61","article-title":"Laminopathies: a wide spectrum of human diseases","volume":"8","author":"Worman","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"2026101520031714800_dgag256-B27","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1152\/physrev.00047.2005","article-title":"Nuclear lamins: laminopathies and their role in premature ageing","volume":"86","author":"Broers","year":"2006","journal-title":"Physiol Rev"},{"issue":"6937","key":"2026101520031714800_dgag256-B28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature01629","article-title":"Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome","volume":"423","author":"Eriksson","year":"2003","journal-title":"Nature"},{"issue":"5","key":"2026101520031714800_dgag256-B29","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1210\/er.2018-00138","article-title":"Bone marrow adiposity: basic and clinical implications","volume":"40","author":"Sebo","year":"2019","journal-title":"Endocr Rev"},{"issue":"21","key":"2026101520031714800_dgag256-B30","doi-asserted-by":"crossref","first-page":"e160915","DOI":"10.1172\/jci.insight.160915","article-title":"Constitutive bone marrow adipocytes suppress local bone formation","volume":"7","author":"Li","year":"2022","journal-title":"JCI Insight"},{"key":"2026101520031714800_dgag256-B31","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2147\/CIA.S466446","article-title":"Bone marrow adipose tissue as a critical regulator of postmenopausal osteoporosis: a concise review","volume":"19","author":"Niu","year":"2024","journal-title":"Clin Interv Aging"},{"issue":"6","key":"2026101520031714800_dgag256-B32","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11914-019-00550-w","article-title":"Marrow fat-secreted factors as biomarkers for osteoporosis","volume":"17","author":"Herrmann","year":"2019","journal-title":"Curr Osteoporos Rep"},{"issue":"12","key":"2026101520031714800_dgag256-B33","doi-asserted-by":"crossref","first-page":"e31434","DOI":"10.1002\/jcp.31434","article-title":"Interplay between bone marrow adiposity and bone resorption in RANKL-mediated modelled osteoporosis","volume":"239","author":"Rinotas","year":"2024","journal-title":"J Cell Physiol"},{"issue":"3","key":"2026101520031714800_dgag256-B34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ajmg.a.20245","article-title":"Congenital generalized lipodystrophy, mental retardation, deafness, short stature, and slender bones: a newly recognized syndrome?","volume":"121","author":"Rajab","year":"2003","journal-title":"Am J Med Genet A"},{"key":"2026101520031714800_dgag256-B35","doi-asserted-by":"crossref","first-page":"711","DOI":"10.12659\/MSM.890130","article-title":"Differential pattern for regulating insulin secretion, insulin resistance, and lipid metabolism by osteocalcin in male and female T2DM patients","volume":"20","author":"Rui","year":"2014","journal-title":"Med Sci Monit"},{"issue":"7","key":"2026101520031714800_dgag256-B36","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4158\/EP161686.RA","article-title":"Mechanistic insights into osteoporosis in patients with lipodystrophy and review of the literature","volume":"23","author":"Huang","year":"2017","journal-title":"Endocr Pract"},{"issue":"9","key":"2026101520031714800_dgag256-B37","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1073\/pnas.0308744101","article-title":"Serum leptin level is a regulator of bone mass","volume":"101","author":"Elefteriou","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7032","key":"2026101520031714800_dgag256-B38","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature03398","article-title":"Leptin regulation of bone resorption by the sympathetic nervous system and CART","volume":"434","author":"Elefteriou","year":"2005","journal-title":"Nature"},{"issue":"2","key":"2026101520031714800_dgag256-B39","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1677\/joe.0.1750405","article-title":"Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo","volume":"175","author":"Cornish","year":"2002","journal-title":"J Endocrinol"},{"issue":"Suppl 3","key":"2026101520031714800_dgag256-B40","doi-asserted-by":"crossref","first-page":"S419","DOI":"10.33549\/physiolres.933733","article-title":"Hormonal and bone parameters in pubertal girls","volume":"66","author":"Cirmanova","year":"2017","journal-title":"Physiol Res"},{"issue":"5","key":"2026101520031714800_dgag256-B41","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/oby.20077","article-title":"Liver fat and SHBG affect insulin resistance in midlife women: the study of Women's health across the nation (SWAN)","volume":"21","author":"Kavanagh","year":"2013","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"2026101520031714800_dgag256-B42","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13023-020-01383-y","article-title":"Genotype-phenotype correlations of Berardinelli-Seip congenital lipodystrophy and novel candidate genes prediction","volume":"15","author":"Ren","year":"2020","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"2026101520031714800_dgag256-B43","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1111\/dom.15061","article-title":"Clinical features of generalized lipodystrophy in Turkey: a cohort analysis","volume":"25","author":"Yildirim Simsir","year":"2023","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"2026101520031714800_dgag256-B44","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ecl.2017.01.012","article-title":"Genetics of lipodystrophy","volume":"46","author":"Lightbourne","year":"2017","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"11","key":"2026101520031714800_dgag256-B45","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.3390\/ijms26115416","article-title":"The role of the AGPAT2 gene in adipose tissue biology and congenital generalized lipodystrophy pathophysiology","volume":"26","author":"de Melo","year":"2025","journal-title":"Int J Mol Sci"},{"key":"2026101520031714800_dgag256-B46","first-page":"17","article-title":"European lipodystrophy registry: background and structure","volume-title":"Orphanet J Rare Dis","author":"von Schnurbein","year":"2020"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag256\/68698511\/dgag256.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/11\/3005\/68698511\/dgag256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/11\/3005\/68698511\/dgag256.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:03:28Z","timestamp":1792109008000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/11\/3005\/8725089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":46,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,7,6]]},"published-print":{"date-parts":[[2026,10,16]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgag256","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11]]},"published":{"date-parts":[[2026,7,6]]}}}